BrightFundedvs DNA Funded
Two mid-tier CFD firms with overlapping spec sheets. BrightFunded leads on payout speed and Trustpilot depth; DNA Funded leads on TradingView integration and scaling cap.
BrightFunded
Payout-speed leader — 4-hour median, up to 100% split
DNA Funded
TradeLocker + TradingView, 90% split, scaling to $600K
BrightFunded and DNA Funded sit in the same competitive tier — mid-cap CFD firms launched in 2023-2024, both running on synthetic execution against external price feeds, both targeting traders who want a polished web platform without the operational friction of a forex-heritage giant. The marketing spec sheets read similar at first glance. Where they diverge is the texture: BrightFunded prioritises payout speed and trust signals with 4-hour USDC payouts and 2,100 Trustpilot reviews; DNA Funded prioritises platform UX and scaling ceiling with native TradingView charting and a $600K cap. The right pick depends on whether you optimise for cash velocity or capital depth.
Trust signals and operational maturity
BrightFunded has roughly 2,100 Trustpilot reviews at 4.7 stars since 2023 — among the strongest Trustpilot signals in our entire coverage of CFD-track firms. DNA Funded has 620 reviews at 4.4 stars since 2024, a thinner but still defensible footprint. The 3-4× review-count gap reflects the year of head-start; the 0.3-star rating gap is small enough to be inside the noise of review-cohort composition. For a first-time trader optimising for the safest trust signal, BrightFunded is the cleaner pick. For a trader comfortable with a younger firm in exchange for better platform UX, DNA Funded is a defensible alternative.
Payout speed and rails
BrightFunded ships USDC on Ethereum or Polygon with a 4-hour median — the joint fastest in our coverage alongside Breakout (which runs Solana). Payouts are on-demand with no cooldown after first funding. DNA Funded ships USDT on Tron or USDC on Ethereum with a 24-hour median, weekly cycle. BrightFunded wins the cash-velocity comparison by a clear margin: 4 hours on-demand vs 24 hours weekly is 5-7× the redeployment speed for an active trader. For a trader who recycles capital aggressively, this is a structural advantage. For a swing trader who takes payouts monthly, the difference is negligible.
Profit split, scaling cap, and challenge economics
BrightFunded tops out at a 100% split via the loyalty-unlocked tier system — base 80% climbing to 100% over a sequence of consistent funded months. The 100% tier is structurally unusual in the category. DNA Funded caps at 90% split flat, but scales the funded allocation higher: up to $600K vs BrightFunded's $400K ceiling. The break-even calculation: at equal gross profit, DNA Funded's $600K × 90% = $540K take-home vs BrightFunded's $400K × 100% = $400K. The scaling cap is more economically consequential than the split percentage for traders who reach the upper tiers — DNA Funded wins on lifetime earnings if you actually scale that high. For most traders who never reach $400K, BrightFunded's higher split is the practical advantage.
Platform and trading conditions
BrightFunded runs on Match-Trader — clean, web-based, lightweight. DNA Funded runs on TradeLocker with native TradingView chart integration. The TradingView integration is the standout: traders who already use TradingView for analysis can place orders directly from the charting environment without switching applications. For chart-driven discretionary traders this is a meaningful UX upgrade. For automated or rule-based traders, the platform choice is less consequential because neither firm allows Expert Advisors or copy trading. Both run 1-step and 2-step challenge formats with similar profit targets (8% BF, 10% DNA) and identical drawdown structures (5% daily / 10% max, trailing).
Pair coverage and leverage
BrightFunded covers 35 pairs with 10× leverage on majors, 5× on alts. DNA Funded covers 20 pairs with 5× leverage on majors, 3× on alts. BrightFunded wins both dimensions — more pairs available and higher leverage ceilings. For altcoin or rotation strategies, the 35-pair menu is materially more flexible than DNA Funded's 20. For high-leverage majors trading, BrightFunded's 10× is double DNA Funded's ceiling. DNA Funded's narrower menu skews toward majors and top-cap alts; BrightFunded reaches further down the cap curve.
Country eligibility and onboarding
Both firms restrict US, Canada, and the standard sanctions list (Iran, North Korea, Syria, Russia, Cuba). Both require KYC at challenge purchase. BrightFunded accepts a broader payment-rail set on the funding side (crypto, bank, card); DNA Funded leans on crypto plus bank wire. Onboarding friction is similar — neither has a meaningful advantage. Both offer pt-BR interface translation, though BrightFunded's pt-BR support depth (FAQ, terms, marketing) is more complete; DNA Funded provides translated marketing but English-only support.
Side-by-side.
| Metric | BrightFunded | DNA Funded |
|---|---|---|
| Editorial score | 4.6★ | 4.3 |
| Trustpilot | 4.7 (2,100) | 4.4 (620) |
| Execution type | mixed | cfd |
| Exchange backing | match-trader | tradelocker, mt5-synthetic |
| Platforms | Match-Trader, TradingView | TradeLocker, TradingView, MT5 |
| Pairs | 35+★ | 20+ |
| Leverage (majors) | 10×★ | 5× |
| Profit split (max) | 100%★ | 90% |
| Max scaling | $400K | $600K★ |
| Payout speed | 4h★ | 24h |
| Payout methods | USDT, USDC, Wise, Bank | USDT, USDC, Bank, Wise |
| Daily drawdown | 5% | 5% |
| Max drawdown | 10% | 10% |
| Drawdown type | trailing | trailing |
| Weekend hold | ✓ | ✓ |
| EAs allowed | ✓ | ✓ |
Pick by use case.
Fastest payout cycle
BrightFunded's 4-hour median vs DNA Funded's 24 hours weekly. 5-7× faster capital redeployment for active traders.
TradingView-native workflow
DNA Funded's TradeLocker + TradingView integration vs BrightFunded's Match-Trader web platform.
Maximum funded allocation
DNA Funded scales to $600K vs BrightFunded's $400K cap. Structural advantage for traders who reach the top scaling tier.
Highest profit split at maturity
BrightFunded's 100% loyalty-unlocked tier vs DNA Funded's 90% flat. Equal-allocation comparison favours BrightFunded.
Wider pair coverage and altcoin rotation
BrightFunded's 35 pairs vs DNA Funded's 20. More flexibility for strategies that rotate beyond top-10 names.
First-time CFD-track trader
BrightFunded's 2,100 Trustpilot reviews (vs DNA Funded's 620) and 12-month longer track record. Stronger trust signal for a first commitment.
Higher-leverage majors trading
BrightFunded's 10× majors leverage vs DNA Funded's 5×. Double the sizing ceiling on BTC/ETH directional bets.
12% OFF Challenge
Payout-speed leader — 4-hour median, up to 100% split
Get discount →